4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Allarity Therapeutics, Inc. (ALLR) operates in the Biotechnology industry and is headquartered in Tarpon Springs, United States with about 7 employees. Its market capitalization is roughly $19 million. In the fiscal year ended 2025-12-31, ALLR reported $0M in revenue and ($11M) in net income.
Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States.
Interactive charts & full statements → Open the ALLR valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($13M) | ($18M) | ($17M) | ($17M) | — |
| Net Income | ($11M) | ($24M) | ($12M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($3M) | ($2M) | ($4M) | ($3M) | — |
| Net Income | ($3M) | ($3M) | ($3M) | ($2M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $18M | $23M | $12M | $14M | — |
| Total Liabilities | $8M | $11M | $15M | $13M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALLR viewer.
About TickerBase · Data methodology & sources